MedTrace Logo

Evaluation of the Effects of a L.Reuteri Strain on Markers of Inflammation, Cardiovascular Risk and Fatty Liver Disease

NCT02972567 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-07-13

No results posted yet for this study

Summary

The purpose of this study is the evaluation of the effects in obese patients with metabolic syndrome on the composition of the intestinal microbiota, markers of the syndrome (hypertension, dyslipidemia, inflammation biomarkers, risk cardiovascular and hepatic steatosis) and other possible metabolites involved.

Conditions

  • Metabolic Syndrome X

Interventions

DIETARY_SUPPLEMENT

Lactobacillus spp

9 log10 cfu/capsule. 1 capsule/day for 12 weeks

DIETARY_SUPPLEMENT

Control

Maltodextrin

Sponsors & Collaborators

  • Universidad de Granada

    collaborator OTHER

  • Complejo Hospitalario de Jaen

    collaborator UNKNOWN

  • Biosearch S.A.

    lead INDUSTRY

Principal Investigators

  • Gil Ángel, Prof. Ph.D · University of Granada (Spain)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02972567 on ClinicalTrials.gov